Al Robichaud

Al Robichaud

Privat kapitalinvesterare på
Cure Ventures Management LP
65 år
Consumer Services
Health Technology
Commercial Services

Profil

Albert J.
Robichaud
is currently a Partner at Cure Ventures Management LP since 2024.
Previously, he was the Chief Scientific Officer at SAGE Therapeutics, Inc. from 2011 to 2023, and held positions as Senior Director & Head-Neuroscience Discovery at Wyeth Research from 2002 to 2010, and VP-Chemistry & Pharmacokinetic Sciences at Lundbeck, Inc. from 2010 to 2011.
He also worked as VP-Chemistry & Pharmacokinetic Sciences at Lundbeck USA Inc. Additionally, he received an undergraduate degree from Rensselaer Polytechnic Institute and a doctorate degree from the University of California, Irvine.

Aktiva positioner av Al Robichaud

FöretagPositionStart
Privat kapitalinvesterare 2024-01-01

Tidigare kända positioner av Al Robichaud

FöretagPositionSlut
SAGE THERAPEUTICS, INC. Teknisk/Vetenskaplig/F&U Direktör 2023-10-09
Företagsledare/Principal 2011-01-01
Direktör/Styrelseledamot 2010-01-01
Lundbeck USA Inc.
Företagsledare/Principal -
Se detaljerna i Al Robichauds erfarenhet

Al Robichauds utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

62

Första gradens relationer

7

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag7

Consumer Services

Consumer Services

Commercial Services

Health Technology

Lundbeck USA Inc.

Health Technology

Finance

  1. Börsen
  2. Insiders
  3. Al Robichaud